01:23 PM EDT, 05/23/2025 (MT Newswires) -- Imunon ( IMNN ) said Friday it received positive data showing improvement in overall and progression-free survival from a phase 2 study of IMNN-001, an investigational therapy for the treatment of advanced ovarian cancer.

Shares more than doubled as intraday trading volume catapulted to over 330.6 million from a daily average of about 532,000.

Merus (MRUS) shares soared 36% amid heavy trading after the company reported favorable interim cancer trial results overnight.

Over 5.63 million shares traded intraday versus a daily average of roughly 836,000.

Douglas Elliman ( DOUG ) has received a merger offer from Anywhere Real Estate (HOUS) this week that would value the company at roughly double its current share price, Bloomberg reported Friday, citing people with knowledge of the matter.

Shares soared 33%, with intraday trading volume at nearly 12 million compared with a daily average of roughly 543,000.

Price: 1.10, Change: +0.68, Percent Change: +164.74